Spokane, Washington. – With its first foray into medical devices, Schweitzer Engineering Laboratories hopes to help children with autistic spectrum disorder that are diagnosed and care for life earlier.
Pullman’s manufacturer recently announced that it advances with efforts to carry a medical technology of hand autism technology to clinics throughout the country, after acquiring intellectual property in 2024 and hiring the researcher who developed it at the State University of Washington Spokane.
Although federal approval has not yet received, the device can detect atypical light reactions in the pupils of a child, which research has proven to be an autism indicator.
Advertisement – Continue reading next
Autism is a disability of development that affects approximately 1 in 36 children, according to disease control and prevention centers. Although there are differences in a spectrum, autism often causes problems with communication and social interaction, and restricted or repetitive interests or interests.
It does not provide a clear diagnosis, but the data that the device meets through the analysis of the student’s activity would be an invaluable tool in the detection process for doctors, said Georgina Lynch, the researcher who developed a prototype while being an associated teacher in The WSU Elson S. Floyd College of Medicine.
Schweitzer Engineering bought technology in 2024 and hired Lynch to supervise the medical devices responsible for their development.
“We believe that there is the need for physical markers associated with autism to help guide the detection process,” Lynch said.
Sampling at a speed of 80 paintings per second, the 6 -inch wide device takes photos of the eye while responding to the light, said Lynch.
He explained that his research, as well as that of his classmates from other institutions, has shown that the reflection of pupillary light provides a kind of window to a child’s brain activity. The efficiency of the nerves for the light reflex indirectly allows doctors to measure the efficiency of cranial nerves in the brain rod.
“It’s more than just looking at the eye and response to light,” Lynch said. “It is more about understanding what happens in the brain trunk and autism that is significantly different from typical development, and that is a new understanding.”
The device is an innovation itself, Lynch said, but so is that new understanding. She and the company imagine that the device will be used in standard checks, together with other non -invasive projections such as auditory evaluations, high and weight measurements or reflex tests with a rubber hammer.
“The analogy we use is that it is very similar to its blood pressure,” Lynch said. “I would not send it to a cardiologist without taking a minimum measurement of what its blood pressure is.”
Lynch said that the average age of the diagnosis is still around 4 years, despite all the advances to understand autism neuroscience in recent decades. Detection measures may vary, and many are based on behavioral characteristics, which can make a diagnosis to be a long and subjective process.
The data provided by the device are one of the few tools for detecting available objectives, he said. That could make a difference in achieving a diagnosis and finding attention and resources from the beginning, which leads to better results for these children in the future.
Implementing the device in a family practice and a standard clinical environment could also decompose part of the stigma around autism, Lynch added.
“We see this technology as something that could be used in routine attention, which opens the conversation and serves as a physical indicator for the probability of ASD,” Lynch said. “At first, your doctor may be attentive to that and start the conversation, whether there is concern or not.”
Dawn Sidell, a registered nurse and director of the Northwest Autism Center, said that early intervention can make a monumental difference in the life of a child. She emphasized the value and uniqueness of having an objective database for reference when detecting autism.
“Help children learn to speak before, process before and commit to people around them in their environments can really really have exponential benefits for future results,” he said. “So, as soon as possible we can involve a child in early intervention services, the better it will be for them and their families.”
For Sidell, the eventual launch of the device will be a complete circle moment. The non -profit organization based in Spokane that offers treatment, nutrition, support of parents and other services was a place of some of Lynch’s research over the years.
“It was quite exciting to be on the first line of a device that really provides a biometric evaluation in the detection process, you know?” Sidell said.
It is the objective of the researchers who work to improve the lives of others so that their findings translate into significant impacts in the public, said Lynch. While some aspects of the Academy are lost, he said that his new home in Schweitzer shares the underlying objective of innovation for the public good.
She is excited about what will come as a researcher and as a clinic who worked with children with autism and their families for many years. Lynch and the company are still working through the regulatory and compliance requirements of the drug and food administration of the United States, which expect to take much of the year.
“The idea that we could associate between the academy and the industry to bring something to help children is simply an incredible honor and opportunity,” Lynch said. “Being able to be in charge and the center and part of that active commitment, both between the side of the technology of things and the medical care system, is really a unique opportunity.”
© 2025 The Spokesman-Review
Distributed by Tribune Content Agency, LLC
